One of the strategic objectives of the 2011–2020 Global Vaccine Action Plan is for the
benefits of immunisation to be equitably extended to all people. This approach …

Vaccination has been an important healthcare measure in preventing infectious diseases.
The response to vaccination is reduced in immunocompromised patients, primary immune …

Background: Pneumococcal disease remains a public health priority in adults. Safety and
immunogenicity of 2 different formulations of 15-valent pneumococcal conjugate vaccine …

The addition of pneumococcal conjugate vaccines (PCVs) to the United States (US) national
immunization program led to significant reductions in incidence, mortality, and associated …

Moraxella catarrhalis is found almost exclusively within the human respiratory tract. This
pathobiont is associated with ear infections and the development of respiratory illnesses …

Background Despite the widespread availability of pneumococcal vaccines, rates of
pneumococcal disease are disproportionately high in adults with chronic and …

Abstract Background The Centers for Disease Control and Prevention's Advisory Committee
on Immunization Practices recommends pneumococcal vaccination for adults with chronic or …

Introduction We compared co-administration versus separate administration of an
inactivated quadrivalent influenza vaccine (IIV4) with a 23-valent pneumococcal …

Streptococcus pneumoniae (Spn) is a bacterial pathogen known to colonize the upper
respiratory tract and cause serious opportunistic diseases such as pneumonia, bacteremia …

Abstract Background The Community Acquired Pneumonia immunization Trial in Adults
(CAPiTA) was conducted to evaluate 13-valent pneumococcal conjugate vaccine (PCV13) …